Across TCGA pan-cancer cohorts, LINC02144 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02144’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02144 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02144 is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.
BRCA and THCA are the cancer types where LINC02144 tumor–normal differential expression is most reproducible.